1. Home
  2. ARGX
  3. ARGX News

Latest argenx SE (ARGX) News on April 2, 2025

Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?
ARGX

Zacks

16 days ago

Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains?

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate
ARGX

Insider Monkey

22 days ago

Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting
ARGX

GlobeNewswire

a month ago

argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity
ARGX

Investor's Business Daily

a month ago

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

ARGX

Morningstar Research

a month ago

Analyst Report: argenx SE

ARGX

MT Newswires

a month ago

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says

Exploring 3 High Growth Tech Stocks in Europe
ARGX

Simply Wall St.

a month ago

Exploring 3 High Growth Tech Stocks in Europe

ARGX

MT Newswires

a month ago

Argenx Q4 Swings to Earnings, Operating Income Increases

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update
ARGX

GlobeNewswire

a month ago

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

argenx to Present at TD Cowen 45th Annual Healthcare Conference
ARGX

GlobeNewswire

a month ago

argenx to Present at TD Cowen 45th Annual Healthcare Conference

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
ARGX

Investor's Business Daily

a month ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
ARGX

GlobeNewswire

a month ago

argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025

Here’s Why argenx SE (ARGX) Rose in Q4
ARGX

Insider Monkey

a month ago

Here’s Why argenx SE (ARGX) Rose in Q4

ARGX

Thomson Reuters StreetEvents

a month ago

Q4 2024 Halozyme Therapeutics Inc Earnings Call

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
ARGX

Zacks

2 months ago

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

Exploring High Growth Tech Stocks With Promising Potential
ARGX

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks With Promising Potential

Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?
ARGX

Insider Monkey

2 months ago

Is argenx SE (ARGX) the High Growth International Stock to Invest in Now?

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?
ARGX

Insider Monkey

2 months ago

Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now?

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?
ARGX

Zacks

3 months ago

Earnings Estimates Rising for Argenx (ARGX): Will It Gain?

argenx Highlights 2025 Strategic Priorities
ARGX

GlobeNewswire

3 months ago

argenx Highlights 2025 Strategic Priorities

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference
ARGX

GlobeNewswire

3 months ago

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference

Exploring High Growth Tech Stocks for January 2025
ARGX

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks for January 2025

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment
ARGX

TipRanks

3 months ago

Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment

ARGX

MT Newswires

3 months ago

Wedbush Raises Argenx's Price Target to $665 From $655, Maintains Outperform Rating

ARGX

MT Newswires

3 months ago

Argenx Says Japan Approves Vyvdura Injection for Chronic Inflammatory Demyelinating Polyneuropathy

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
ARGX

GlobeNewswire

3 months ago

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

Is Argenx SE (ARGX) the Best Performing Biotech Stock in 2024?
ARGX

Insider Monkey

3 months ago

Is Argenx SE (ARGX) the Best Performing Biotech Stock in 2024?

Here’s Why argenx SE (ARGX) Surged in Q3
ARGX

Insider Monkey

4 months ago

Here’s Why argenx SE (ARGX) Surged in Q3

Should You Increase Your Holdings in argenx SE (ARGX)?
ARGX

Insider Monkey

4 months ago

Should You Increase Your Holdings in argenx SE (ARGX)?

Three Stocks Estimated To Be Undervalued In December 2024
ARGX

Simply Wall St.

4 months ago

Three Stocks Estimated To Be Undervalued In December 2024

Spotlight On High Growth Tech Stocks This December 2024
ARGX

Simply Wall St.

4 months ago

Spotlight On High Growth Tech Stocks This December 2024

Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now?
ARGX

Insider Monkey

4 months ago

Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now?

argenx to Present at Upcoming Investor Conferences
ARGX

GlobeNewswire

4 months ago

argenx to Present at Upcoming Investor Conferences

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial
ARGX

BioPharma Dive

4 months ago

Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial

ARGX

MT Newswires

4 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

ARGX

MT Newswires

4 months ago

Sector Update: Health Care

ARGX

MT Newswires

4 months ago

Argenx to Continue Development of Autoimmune Disease Drug After Phase 2/3 Data

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
ARGX

GlobeNewswire

4 months ago

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?
ARGX

Insider Monkey

4 months ago

Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now?

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
ARGX

GlobeNewswire

5 months ago

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
ARGX

Business Wire

5 months ago

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China

Why Argenx (ARGX) Might be Well Poised for a Surge
ARGX

Zacks

5 months ago

Why Argenx (ARGX) Might be Well Poised for a Surge

argenx to Participate at Upcoming Investor Conferences
ARGX

GlobeNewswire

5 months ago

argenx to Participate at Upcoming Investor Conferences

Three Value Stocks Priced Below Estimated Worth In November 2024
ARGX

Simply Wall St.

5 months ago

Three Value Stocks Priced Below Estimated Worth In November 2024

High Growth Tech Stocks To Watch In November 2024
ARGX

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In November 2024

Argenx price target raised to $660 from $540 at Truist
ARGX

TipRanks

5 months ago

Argenx price target raised to $660 from $540 at Truist

argenx SE (ARGNF) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Challenges
ARGX

GuruFocus.com

5 months ago

argenx SE (ARGNF) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Challenges

ARGX

Morningstar Research

5 months ago

Analyst Report: argenx SE

Here’s Why You Should Hold Argenx SE (ARGX)
ARGX

Insider Monkey

5 months ago

Here’s Why You Should Hold Argenx SE (ARGX)

ARGX

MT Newswires

5 months ago

Argenx Swings to Q3 Profit, Total Operating Income Increases

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update
ARGX

GlobeNewswire

5 months ago

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
ARGX

GlobeNewswire

5 months ago

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

Discover October 2024's Stocks Estimated To Be Trading Below Fair Value
ARGX

Simply Wall St.

5 months ago

Discover October 2024's Stocks Estimated To Be Trading Below Fair Value

Multiple Tailwinds Lifted argenx SE (ARGX) in Q3
ARGX

Insider Monkey

6 months ago

Multiple Tailwinds Lifted argenx SE (ARGX) in Q3

ARGX

MT Newswires

6 months ago

Argenx Says New Data on its Generalized Myasthenia Gravis Treatments Demonstrate 'Sustained Responses'

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions
ARGX

GlobeNewswire

6 months ago

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

argenx SE (ARGNF) Q2 2024 Earnings Call Highlights: Strong Financial Performance Amid ...
ARGX

GuruFocus.com

6 months ago

argenx SE (ARGNF) Q2 2024 Earnings Call Highlights: Strong Financial Performance Amid ...

Zacks.com featured highlights include Argenx SE Alphatec and Olin
ARGX

Zacks

6 months ago

Zacks.com featured highlights include Argenx SE Alphatec and Olin

3 Best Earnings Acceleration Stocks to Buy in a Strong Q4
ARGX

Zacks

6 months ago

3 Best Earnings Acceleration Stocks to Buy in a Strong Q4

Discovering argenx And 2 More Stocks That May Be Priced Below Estimated Value
ARGX

Simply Wall St.

6 months ago

Discovering argenx And 2 More Stocks That May Be Priced Below Estimated Value

ARGX

MT Newswires

6 months ago

Halozyme Therapeutics Expands Licensing Agreement With Argenx

High Growth Tech Stocks To Watch In October 2024
ARGX

Simply Wall St.

6 months ago

High Growth Tech Stocks To Watch In October 2024

Biotech Leader Argenx In Buy Zone, Poised To Hit New Highs
ARGX

Investor's Business Daily

6 months ago

Biotech Leader Argenx In Buy Zone, Poised To Hit New Highs

Amgen stock falls on lackluster drug data
ARGX

Yahoo Finance Video

6 months ago

Amgen stock falls on lackluster drug data

Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases
ARGX

Investor's Business Daily

6 months ago

Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
ARGX

GlobeNewswire

6 months ago

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

Here’s Why argenx SE (ARGX) Rose 9% in Q2
ARGX

Insider Monkey

7 months ago

Here’s Why argenx SE (ARGX) Rose 9% in Q2

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
ARGX

Investor's Business Daily

7 months ago

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

Argenx (ARGX) Moves 4.0% Higher: Will This Strength Last?
ARGX

Zacks

7 months ago

Argenx (ARGX) Moves 4.0% Higher: Will This Strength Last?

3 Stocks Estimated To Be Up To 45% Below Intrinsic Value
ARGX

Simply Wall St.

7 months ago

3 Stocks Estimated To Be Up To 45% Below Intrinsic Value

Exploring High Growth Tech Stocks for September 2024
ARGX

Simply Wall St.

7 months ago

Exploring High Growth Tech Stocks for September 2024

Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
ARGX

Benzinga

7 months ago

Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB

argenx to Present at Upcoming Investor Conferences
ARGX

GlobeNewswire

7 months ago

argenx to Present at Upcoming Investor Conferences

Biotech stocks: Which drugmakers are worth a buy?
ARGX

Yahoo Finance Video

8 months ago

Biotech stocks: Which drugmakers are worth a buy?

Three Stocks That Could Be Trading Below Fair Value In July 2024
ARGX

Simply Wall St.

8 months ago

Three Stocks That Could Be Trading Below Fair Value In July 2024

Argenx (ARGX) Upgraded to Buy: Here's What You Should Know
ARGX

Zacks

8 months ago

Argenx (ARGX) Upgraded to Buy: Here's What You Should Know

ARGX

MT Newswires

8 months ago

Baird Adjusts Price Target on Argenx to $515 From $490, Maintains Outperform Rating

ARGX

Morningstar Research

8 months ago

Analyst Report: argenx SE

ARGX

MT Newswires

8 months ago

Argenx Swings to Q2 Profit, Total Operating Income Rises

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update
ARGX

GlobeNewswire

8 months ago

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
ARGX

GlobeNewswire

8 months ago

argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024

What Made argenx SE (ARGX) Rise in Q2?
ARGX

Insider Monkey

9 months ago

What Made argenx SE (ARGX) Rise in Q2?

ARGX

MT Newswires

9 months ago

Argenx, Zai Lab Get Chinese Regulator's Nod for Subcutaneous Add-on Injection Targeting Eneralized Myasthenia Gravis

argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
ARGX

GlobeNewswire

9 months ago

argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China
ARGX

Business Wire

9 months ago

Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China

Hidden Gems: Three Stocks Estimated Below Market Value in June 2024
ARGX

Simply Wall St.

9 months ago

Hidden Gems: Three Stocks Estimated Below Market Value in June 2024

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting
ARGX

GlobeNewswire

9 months ago

argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting

Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains?
ARGX

Zacks

9 months ago

Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains?

ARGX

MT Newswires

9 months ago

Argenx Shares Rise Following Vyvgart Hytrulo Approval

FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
ARGX

Zacks

9 months ago

FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder

Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval
ARGX

Investor's Business Daily

9 months ago

Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval

FDA approves argenx’s VYVGART Hytrulo for CIDP treatment
ARGX

Pharmaceutical Technology

9 months ago

FDA approves argenx’s VYVGART Hytrulo for CIDP treatment

ARGX

Investing.com

9 months ago

Argenx soars on CIDP shot approval

ARGX

MT Newswires

9 months ago

argenx Says FDA Approved Vyvgart Hytrulo for Treatment of Neuromuscular Disorder

argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
ARGX

GlobeNewswire

9 months ago

argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy

ARGX

MT Newswires

10 months ago

Wedbush Adjusts Price Target on argenx to $519 From $521, Maintains Outperform Rating

argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024
ARGX

GlobeNewswire

10 months ago

argenx to unveil its ‘Vision 2030: Taking Breakthrough Science to 50,000 Patients’ during its Upcoming R&D Day on July 16, 2024

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
ARGX

Business Insider

10 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
ARGX

Insider Monkey

10 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
ARGX

Reuters

10 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Share on Social Networks: